closthioamide: from the strictly anaerobic bacterium Clostridium; structure in first source
ID Source | ID |
---|---|
PubMed CID | 135937227 |
SCHEMBL ID | 12655890 |
MeSH ID | M0547145 |
Synonym |
---|
SCHEMBL12655890 |
closthioamide |
CS-0021436 |
HY-101472 |
1227367-59-0 |
IQ4 , |
AKOS040732833 |
Closthioamide (CTA) is a symmetric nonribosomal peptide (NRP) comprised of two diaminopropane-linked polythioamidated monomers. It is one of only a handful of secondary metabolites described from obligately anaerobic bacteria.
Excerpt | Reference |
---|---|
"Closthioamide (CTA) is a rare example of a thioamide-containing nonribosomal peptide and is one of only a handful of secondary metabolites described from obligately anaerobic bacteria. " | ( Reconstitution of polythioamide antibiotic backbone formation reveals unusual thiotemplated assembly strategy. Dell, M; Dunbar, KL; Gude, F; Hertweck, C, 2020) |
"Closthioamide (CTA) is a symmetric nonribosomal peptide (NRP) comprised of two diaminopropane-linked polythioamidated monomers. " | ( An Unexpected Split-Merge Pathway in the Assembly of the Symmetric Nonribosomal Peptide Antibiotic Closthioamide. Büttner, H; Dell, M; Dunbar, KL; Hertweck, C; Kumpfmüller, J; Molloy, EM, 2021) |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (11.11%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |